prodrome 发表于 2025-3-25 07:14:04

http://reply.papertrans.cn/2/149/14832/14832-21.png

摇曳 发表于 2025-3-25 10:02:25

http://reply.papertrans.cn/2/149/14832/14832-22.png

minion 发表于 2025-3-25 11:54:19

http://reply.papertrans.cn/2/149/14832/14832-23.png

Latency 发表于 2025-3-25 16:17:33

http://reply.papertrans.cn/2/149/14832/14832-24.png

说不出 发表于 2025-3-26 00:01:47

http://reply.papertrans.cn/2/149/14832/14832-25.png

致命 发表于 2025-3-26 01:56:12

Submitted on: 22 January 2022.
Revised on: 22 March 2022.
Accepted on: 06 April 2022.

___________________JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Pert敏捷 发表于 2025-3-26 04:48:04

Submitted on: 17 December 2001.
Revised on: 27 March 2002.
Accepted on: 13 May 2002.

___________________JAPANESE JOURNAL OF CLINICAL ONCOLOGY

FACT 发表于 2025-3-26 09:39:38

Submitted on: 26 March 2021.
Revised on: 14 July 2021.
Accepted on: 04 August 2021.

___________________JAPANESE JOURNAL OF CLINICAL ONCOLOGY

我怕被刺穿 发表于 2025-3-26 13:24:28

http://reply.papertrans.cn/2/149/14832/14832-29.png

欢乐中国 发表于 2025-3-26 17:11:33

http://reply.papertrans.cn/2/149/14832/14832-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2024/2025影响因子:1.981 (JPN J CLIN ONCOL) (0368-2811). (ONCOLOGY)(肿瘤学)Science